Search Results 191-200 of 18713 for hepatitis

  1. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    ... hepatitis C recurrence and who have a serious or immediately life ... hepatitis.This protocol will be opened at specific clinical sites for the ...

  2. Drugs and Supplements that Start with H - Mayo Clinic

    Habitrol. Also known as · HAD. Also known as · Hadlima. Also known as · Hadlima. Also known as · Haegarda. Also known as · Haemophilus b conjugate and hepatitis b ...

  3. International and National Data and Sample Registry - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

    ... hepatitis C virus infection to hepatocellular carcinoma, and clinical outcomes of patients with hepatocellular carcinoma by using a high-density single ...

  4. HIV/AIDS - Symptoms and causes - Mayo Clinic

    If you have hepatitis B, you should see an infectious disease or liver specialist before beginning PrEP therapy. Use treatment as prevention, also called TasP.

  5. Nausea and vomiting - Mayo Clinic

    Skin rash? Use the Symptom Checker to find out what's causing your symptom. Tapeworm infection · Testicular torsion · Thunderclap headaches · Toxic hepatitis.

  6. Digestive Diseases Calculators - Medical Professionals - Mayo Clinic

    MELD Score and 90-Day Mortality Rate for Alcoholic Hepatitis ...

  7. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  8. Sofosbuvir, velpatasvir, and voxilaprevir (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis B infection, history of—Use with caution. May cause this disease to become active again. Liver disease, moderate or severe—Use is not recommended ...

  9. The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic

    Learn more about research related to ANI. MELD calculations may also be performed for the 90-days mortality rate of Alcoholic Hepatitis. Related Content ...

  10. centers-of-excellence

    Interventiona... A Study for the Use of Hepatitis C Virus Seropositive Donors into Hepatitis C Seronegative Liver Transplant Recipients ...